Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6895588 | 0.97 | SMPD1 (0.33) | CYP3A4TSHRSMPD1 | |
| SCHEMBL6254526 | 0.95 | CYP3A4 (0.33) | CYP3A4TSHRSMPD1 | |
| SCHEMBL6256433 | 0.92 | SMPD1 (0.36) | CYP3A4TSHRSMPD1 | |
| SCHEMBL6258025 | 0.89 | CYP3A4 (0.33) | CYP3A4TSHR | |
| SCHEMBL6899692 | 0.88 | GRM4 (0.32) | — | |
| SCHEMBL6256378 | 0.82 | GRM4 (0.35) | — | |
| SCHEMBL3046352 | 0.79 | LPAR3 (0.41) | CYP3A4TSHRSMPD1 | |
| SCHEMBL13953196 | 0.78 | LPAR3 (0.44) | SMPD1 | |
| SCHEMBL6256820 | 0.78 | LPAR3 (0.40) | CYP3A4TSHRSMPD1 | |
| SCHEMBL3044808 | 0.77 | LPAR3 (0.44) | SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004529069-A | — | — | 2004-09-24 | — | — | JP | claimed |
| EP-1351916-A2 | ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | Esperion Therapeutics Inc. (US) | 2003-10-15 | — | — | EP | claimed |
| WO-2002030863-A2 | ETHER COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS, INC. (US) | 2002-04-18 | — | — | WO | claimed |
| US-6713507-B2 | CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; ALZHEIMER'S DISEASE | ESPERION THERAPEUTICS, INC. | 2004-03-30 | — | — | US | disclosed |